SearchDictionaryMobileLogin

Benign Neonatal Epilepsy (Benign Familial Neonatal Convulsions)

52  relevant articles (1 outcomes, 0 trials/studies) found for this Disease

Description: A condition marked by recurrent seizures that occur during the first 4-6 weeks of life despite an otherwise benign neonatal course. Autosomal dominant familial and sporadic forms have been identified. Seizures generally consist of brief episodes of tonic posturing and other movements, apnea, eye deviations, and blood pressure fluctuations. These tend to remit after the 6th week of life. The risk of developing epilepsy at an older age is moderately increased in the familial form of this disorder. (Neurologia 1996 Feb;11(2):51-5)

Also Known As:
Benign Familial Neonatal Convulsions; Epilepsy, Benign Neonatal; Benign Familial Neonatal Epilepsy; Benign Neonatal Epilepsy, Nonfamilial; Benign Neonatal Non-Familial Convulsions; Benign Neonatal Nonfamilial Epilepsy; Benign Non-Familial Neonatal Convulsions; Convulsions, Benign Neonatal, Familial; Convulsions, Benign Neonatal, Non-Familial; Epilepsy, Benign Neonatal, Familial; Epilepsy, Benign Neonatal, Non-Familial; Epilepsy, Benign Neonatal, Nonfamilial; Familial Benign Neonatal Convulsions; Familial Benign Neonatal Epilepsy; Non-Familial Benign Neonatal Convulsions; Non-Familial Benign Neonatal Epilepsy; Benign Neonatal Convulsion; Benign Neonatal Convulsions; Benign Neonatal Epilepsies; Benign Neonatal Non Familial Convulsions; Benign Non Familial Neonatal Convulsions; Convulsion, Benign Neonatal; Convulsions, Benign Neonatal; Epilepsies, Benign Neonatal; Neonatal Convulsion, Benign; Neonatal Epilepsies, Benign; Neonatal Epilepsy, Benign; Non Familial Benign Neonatal Convulsions; Non Familial Benign Neonatal Epilepsy; Neonatal Convulsions, Benign

Relationship Network

Disease Context: Research Results

Related Diseases

1. Epilepsy (Aura)
2. Syndrome
3. Frontal Lobe Epilepsy (Epilepsy, Supplementary Motor)
4. Generalized Epilepsy
5. Febrile Seizures (Febrile Seizure)

Experts

1. Castaldo, Pasqualina: 3 articles (05/2007 - 01/2002)
2. Taglialatela, Maurizio: 3 articles (05/2007 - 01/2002)
3. Annunziato, Lucio: 3 articles (05/2007 - 01/2002)
4. Pascotto, Antonio: 3 articles (05/2007 - 01/2002)
5. Soldovieri, Maria Virginia: 2 articles (05/2007 - 01/2006)
6. Bellini, Giulia: 2 articles (05/2007 - 01/2006)
7. Miraglia del Giudice, Emanuele: 2 articles (05/2007 - 01/2006)
8. Miceli, Francesco: 2 articles (05/2007 - 01/2006)
9. Shapiro, Mark S: 1 article (05/2007)
10. Cilio, Maria Roberta: 1 article (05/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Benign Neonatal Epilepsy:
1. Potassium Channels (Potassium Channel)IBA
2. Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
3. Ion Channels (Ion Channel)IBA
01/01/2005 - "Genetic analyses of familial epilepsies over the past decade have identified mutations in several different ion channel genes that result in neonatal or early-onset seizure disorders, including benign familial neonatal convulsions (BFNC), generalized epilepsy with febrile seizures plus (GEFS+), and severe myoclonic epilepsy of infancy (SMEI)"
06/01/2000 - "DEVELOPMENT: We studied the main ion channel disorders related to simply inherited idiopathic epileptic syndromes in which four genes have been codified to date: benign familial neonatal convulsions, generalized epilepsy with febrile seizures plus and autosomal dominant nocturnal frontal lobe epilepsy"
12/01/2006 - "Thus, the discovery of KCNQ2 mutations in benign familial neonatal convulsions, SCN1A mutations in severe myoclonic epilepsy of infancy and in generalized epilepsy with febrile seizures plus, and CHRA4 and CHRB2 mutations in autosomal-dominant nocturnal frontal lobe epilepsy, has led to the establishment of epilepsy as a disorder of ion channel function and, furthermore, has led to the introduction of genetic tests that are available clinically to aid in diagnosis and treatment"
06/01/2000 - "Two human epilepsy syndromes, benign familial neonatal convulsions and generalized epilepsy with febrile seizures plus, represent K+ and Na+ channelopathies, and other newly defined syndromes have now been mapped to chromosomal regions that are rich in ion channel genes"
12/01/2000 - "Recently, gene defects underlying four monogenic epilepsies (generalized epilepsy with febrile seizures, autosomal dominant nocturnal frontal lobe epilepsy, benign familial neonatal convulsions and episodic ataxia type 1 with partial seizures) have been identified, shedding new light on the pathophysiology of epilepsy as these diseases are caused by ion channel mutations"
Order ALL the reference details at left...
4. Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
5. KCNQ3 Potassium ChannelIBA
6. Glutamic Acid (Glutamate)FDA Link
7. Sodium Channels (Sodium Channel)IBA
8. PotassiumIBA
9. KCNQ2 Potassium ChannelIBA
10. Type 3 Melanocortin ReceptorIBA

Best Treatments:
Research Summary Report
on Benign Neonatal Epilepsy
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 1 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>